Cargando…
Propranolol-induced hyperkalemia in infantile hemangioma patients: How serious is it?
BACKGROUND: Infantile hemangioma is the most frequent benign vascular tumor of infancy, which has a specific clinical history of early growth, followed by spontaneous remission. Since the fortuitous discovery of propranolol’s efficacy in 2008, the management of infantile hemangioma has been quickly...
Autores principales: | Alakeel, Abduallah, Alsalman, Hanan, Alotaibi, Ghadah, Somily, Haneen, Alsohime, Fahad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041225/ https://www.ncbi.nlm.nih.gov/pubmed/36993109 http://dx.doi.org/10.4103/jfmpc.jfmpc_658_22 |
Ejemplares similares
-
Propranolol-induced hyperkalemia in the management of infantile hemangioma
por: Al-Rwebah, Huda, et al.
Publicado: (2020) -
Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012) -
Propranolol for treatment of infantile hemangiomas
por: de Melo, Juliana Nakano, et al.
Publicado: (2013) -
Propranolol in the Treatment of Infantile Hemangiomas
por: Tan, Xin, et al.
Publicado: (2021) -
Mechanisms of propranolol action in infantile hemangioma
por: Kum, Jina JY, et al.
Publicado: (2015)